![Tibor Keler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tibor Keler
Founder at
CELLDEX THERAPEUTICS, INC.
Net worth: 280 007 $ as of 30/07/2026
Profile
Tibor Keler is the founder of Celldex Therapeutics, Inc., founded in 1983, holding the title of Chief Scientific Officer & Executive VP since 2014.
The current job is Chief Scientific Officer, VP-Research & Discovery at Celldex Research Corp.
starting in 2003.
Former jobs include Senior Director-Preclinical Development at Medarex, Inc. from 2003 to 2004, Chief Scientific Officer & Senior Vice President at AVANT Immunotherapeutics, Inc. in 2008, and Chief Scientific Officer, VP-Research & Discovery at Celldex Therapeutics, Inc. (Old) from 2003 to 2008.
Education includes a doctorate from the University of Pennsylvania and undergraduate and graduate degrees from Drexel University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/06/2026 | 7,357 ( 0.01% ) | 280 007 $ | 30/07/2026 |
Tibor Keler active positions
| Companies | Position | Start |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Founder | 31/12/1982 |
Celldex Research Corp.
 Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Chief Tech/Sci/R&D Officer | 30/04/2003 |
Former positions of Tibor Keler
| Companies | Position | End |
|---|---|---|
Celldex Therapeutics, Inc. (Old)
 Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Chief Tech/Sci/R&D Officer | 30/09/2008 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Chief Tech/Sci/R&D Officer | 30/09/2008 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Corporate Officer/Principal | 29/02/2004 |
Training of Tibor Keler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
44
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Celldex Therapeutics, Inc. (Old)
Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Celldex Research Corp.
Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Commercial Services |
- Stock Market
- Insiders
- Tibor Keler
